Healthtech Startups

Biograph operates preventive health clinics that conduct comprehensive health assessments combining imaging, blood biomarkers, and cardiac testing to help individuals optimize their healthspan and lifespan. The service targets individuals seeking proactive, personalized health evaluation in a private clinical setting.

2 investors

BioGrip develops non-invasive neuromuscular sensing technology combined with adaptive AI to decode human intention and enable intuitive control of prosthetics, rehabilitation systems, and robotics. The company targets individuals with mobility impairments and muscular or peripheral nerve damage.

2 investors

BioKier develops oral products for managing lipids and glucose in type 2 diabetes and cardiometabolic disorders, designed to replicate the metabolic benefits of bariatric surgery through colon-targeted nutrient delivery. The company is a clinical-stage biotech pursuing regulatory approval via the 505(b)2 NDA pathway.

2 investors

Biologix develops home-based sleep apnea diagnostic solutions combining finger-worn oximetry and position sensors with a mobile app and cloud platform that automatically analyzes results and delivers reports signed by sleep specialists. It serves patients and healthcare professionals through a network of accredited diagnostic centers across Latin America.

2 investors

BiomeBank develops microbiome-based therapies aimed at restoring the gut microbial ecosystem, with a focus on conditions such as inflammatory bowel disease and Clostridioides difficile infection. The company operates a cGMP manufacturing facility in Adelaide and works with academic and hospital research partners on drug discovery and clinical development.

2 investors

Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics. It focuses on drug discovery to address unmet patient needs.

2 investors

Biomoneta develops air decontamination devices that use ZeBox technology to eliminate airborne pathogens and provide medical-grade sterility without ozone or harmful radiation. The company offers medical-grade and consumer-grade air purification systems for hospitals, healthcare facilities, and homes.

2 investors

Bionexo is a technology and intelligence leader for Latin America's health value chain, connecting institutions, suppliers, and professionals on an integrated platform to improve efficiency, transparency, and traceability in critical processes.

2 investors

Bionic Power develops wearable smart orthoses for lower-body mobility assistance in patients with knee pathologies and gait disorders, including conditions like cerebral palsy, spina bifida, and stroke-related hemiparesis. The company's Agilik smart orthosis is designed to enhance walking ability and quality of life in affected patients.

2 investors

Biophytis is a clinical-stage biotechnology company developing drug candidates for age-related diseases and metabolic conditions, with a phase 2 trial in obesity. The company is publicly listed and raises capital from institutional investors to fund its clinical programs.

2 investors

BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain. The company's offerings have anti-inflammation and anti-scarring properties and are used by surgeons and healthcare professionals to help patients heal faster.

2 investors

Biotronics3D provides 3Dnet, a cloud-native medical imaging platform that integrates PACS, RIS, patient portals, and advanced diagnostic visualization tools for healthcare organizations. The solution supports multi-site deployments with AI-driven workflows and enables secure collaboration among healthcare providers and patients.

2 investors

Biotts develops proprietary drug products and transdermal delivery systems for pharmaceutical applications, with a focus on improving patient quality of life.

2 investors

BIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development. Its work spans recombinant proteins, viral vectors, mRNA vaccines, and pharmaceutical process development for the biotech and pharmaceutical industries.

2 investors

BioVersys is a clinical-stage biotech company focused on developing antimicrobial therapies to address unmet medical needs in infectious diseases, including tuberculosis and hospital-acquired infections. The company targets infectious disease indications with next-generation antimicrobial treatments.

2 investors

BIRD INITIATIVE is a Japanese R&D and digital innovation firm that accelerates promising technologies from research into business applications through simulation, automation, and ecosystem support. The company serves corporate clients and researchers seeking to commercialize digital transformation technologies.

2 investors

Bitewing provides a software platform that helps revenue cycle management (RCM) reviewers prioritize insurance claim discrepancies by defensibility, urgency, and financial impact, keeping incomplete or blocked claims out of the active review queue.

2 investors

Bitfount provides a federated learning and data science platform that enables organizations to run AI models, conduct analytics, and perform model training on private data without transferring it to third parties. The platform serves enterprises and research organizations across industries who need to leverage sensitive data while maintaining privacy and governance controls.

2 investors

Bitrobius develops gene therapy technologies, specifically the Gentrafix platform, leveraging microbial molecular biology and genetic engineering. The company serves therapeutic applications in areas including neurodegeneration and drug discovery.

2 investors

Blair builds AI agents that handle patient conversations and administrative tasks such as calls and appointment scheduling for healthcare practices. The product aims to reduce operational workload for clinical teams while maintaining patient trust.

2 investors

Blazar develops software and methods that help biomedical and translational R&D teams structure workflows so that results, model outputs, and supporting evidence remain interpretable, comparable, and traceable as data, instruments, and protocols change over time. Its work originates in AI applied to pathology, biomarkers, and translational modelling in oncology research, and its tools emphasize documented assumptions, structured review, and human supervision.

2 investors

Blocksynop develops the Neural Blockade Monitor, a noninvasive, real-time device for measuring the effectiveness of local anesthetics (neural blocks) in patients. The tool is intended for anesthesiologists and clinical pain management, combining biomedical and systems engineering.

2 investors

Bloom is a customer engagement company that helps private Medicare and other government-related insurance plans, along with their agents and brokers, guide older adults through shopping for, enrolling in, and activating health coverage. It combines a technology platform with a specialty telesales call center to deliver Medicare plan enrollment services across the United States.

2 investors

BloomText provides HIPAA-compliant messaging software built specifically for healthcare organizations. The platform enables secure staff communication across Windows desktops and mobile devices with compliance features built in, requiring no separate configuration or compliance infrastructure.

2 investors